Company intelligence / Profile preview

Incircular

Amsterdam, North Holland, Netherlands

Ownership: Private
Development stage: Other

Overview

Incircular is a platform-based biotech company focusing on computational protein design to enhance the stability and shelf-life of proteins. Their technology utilizes a circularization method to make proteins more robust against thermal and chemical stress, aiming to improve biologics, diagnostics, and industrial enzymes.

Modalities: ProteinRecombinant proteinMonoclonal antibodyEnzymes
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Incircular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Incircular.

Explore the full profile